📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Calimmune

1.1 - Company Overview

Calimmune Logo

Calimmune

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage gene therapies, including a lead gene-based therapeutic candidate engineered to control HIV infection and protect individuals with HIV from progressing to AIDS. The therapy is currently being evaluated in Phase I/II studies. Cal-1 is designed to reduce production of CCR5, a protein.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Calimmune

Poolbeg Pharma Logo

Poolbeg Pharma

HQ: Ireland Website
  • Description: Provider of clinical-stage research and development of novel treatments for infectious diseases, including POLB 001, an oral small molecule for cancer immunotherapy-induced cytokine release syndrome and severe influenza; AI-powered drug discovery leveraging human challenge trial data; and an oral GLP-1 agonist delivery system targeting obesity and other metabolic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Poolbeg Pharma company profile →
Ausper Bio Logo

Ausper Bio

HQ: China Website
  • Description: Provider of biotechnology therapies developing ASO and oligonucleotide-conjugate drugs for chronic hepatitis B and other major infectious diseases, featuring AHB-137 (Phase I) targeting a conserved HBV mRNA region with potential HBsAg reduction and favorable safety, and Med-Oligo platforms that enhance ASO potency and safety, combining small molecule and antibody expertise.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ausper Bio company profile →
Topica Pharmaceuticals Logo

Topica Pharmaceuticals

HQ: United States Website
  • Description: Provider of clinical research-stage topical treatments targeting fungal infections of the nail.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Topica Pharmaceuticals company profile →
NanoCures Logo

NanoCures

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology and infectious disease immunity platforms, including: Cures Platform targeting specific genomic and molecular pathways to yield multiple therapeutics; Data/AI Platform using biometric, genomic, molecular, and environmental data with AI/ML to detect diseases early and guide new cure development; and Developer Platform offering resources, data, and tools to lower barriers and encourage innovation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NanoCures company profile →
Fast Track Diagnostics Logo

Fast Track Diagnostics

HQ: Malta Website
  • Description: Provider of infectious disease diagnostics tests and detection kits using syndromic multiplex real time PCR to distinguish viral, bacterial, or other infections in a single test; a global supplier specializing in the design, development and manufacture of FTD assays.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Fast Track Diagnostics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Calimmune

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Calimmune

2.2 - Growth funds investing in similar companies to Calimmune

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Calimmune

4.2 - Public trading comparable groups for Calimmune

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Calimmune

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Calimmune

What does Calimmune do?

Calimmune is a provider of clinical-stage gene therapies, including a lead gene-based therapeutic candidate engineered to control HIV infection and protect individuals with HIV from progressing to AIDS. The therapy is currently being evaluated in Phase I/II studies. Cal-1 is designed to reduce production of CCR5, a protein.

Who are Calimmune's competitors?

Calimmune's competitors and similar companies include Poolbeg Pharma, Ausper Bio, Topica Pharmaceuticals, NanoCures, and Fast Track Diagnostics.

Where is Calimmune headquartered?

Calimmune is headquartered in United States.

How many employees does Calimmune have?

Calimmune has 1,000 employees 🔒.

When was Calimmune founded?

Calimmune was founded in 2010 🔒.

What sector and industry vertical is Calimmune in?

Calimmune is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Calimmune

Who are the top strategic acquirers in Calimmune's sector and industry

Top strategic M&A buyers and acquirers in Calimmune's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Calimmune?

Top strategic M&A buyers groups and sectors for Calimmune include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Calimmune's sector and industry vertical

Which are the top PE firms investing in Calimmune's sector and industry vertical?

Top PE firms investing in Calimmune's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Calimmune's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Calimmune's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Calimmune's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Calimmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Calimmune's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Calimmune?

The key public trading comparables and valuation benchmarks for Calimmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Calimmune for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Calimmune with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Calimmune's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Calimmune with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Calimmune's' sector and industry vertical?

Access recent funding rounds and capital raises in Calimmune's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Calimmune